Abstract
In the UK, both media and public attention are focused on sildenafil [‘Viagra’; Pfizer]. Secretary of State for Health Frank Dobson has announced which patient groups will qualify for impotence treatments, including ‘Viagra’, on the National Health Service (NHS), effective from 1 July 1999. * Other patients not included in this restrictive prescribing list will be able to get sildenafil from specialists but only in ‘ exceptional cases of extreme distress ’, according to the UK Department of Health. Perhaps prompting this type of decision is the fact that ‘Viagra’ is classified as a ‘lifestyle medicine’ - an intervention for a condition that in itself is not life-threatening. Also, the NHS is worried about the potential for high patient demand for the oral erectile dysfunction (ED) therapy. 1
Additional information
* See Inpharma 1188: 4, 22 May 1999; 800754995
1. UK NHS nervous over Viagra prescribing. Scrip 2370: 4, 16 Sep 1998
Rights and permissions
About this article
Cite this article
Wright, T. ‘Viagra’ making headlines again in the UK. Inpharma Wkly. 1190, 5–6 (1999). https://doi.org/10.2165/00128413-199911900-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199911900-00010